Compton Capital Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Compton Capital Management’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-15,000	Closed	-$5K	–	142
2016 Q3	$5K	Buy	15,000 +5,000	+50%	+$1.67K	﹤0.01%	137
2016 Q2	$5K	Sell	10,000 -10,000	-50%	-$5K	﹤0.01%	143
2016 Q1	$27K	Buy	20,000 +5,000	+33%	+$6.75K	0.02%	141
2015 Q4	$22K	Hold	15,000	–	–	0.01%	138
2015 Q3	$24K	Hold	15,000	–	–	0.01%	131
2015 Q2	$26K	Hold	15,000	–	–	0.01%	140
2015 Q1	$21K	Hold	15,000	–	–	0.01%	138
2014 Q4	$23K	Hold	15,000	–	–	0.01%	143
2014 Q3	$31K	Hold	15,000	–	–	0.02%	137
2014 Q2	$46K	Buy	+15,000	New	+$46K	0.02%	138
2014 Q1	–	Sell	-12,000	Closed	-$60K	–	146
2013 Q4	$60K	Hold	12,000	–	–	0.03%	137
2013 Q3	$27K	Hold	12,000	–	–	0.02%	139
2013 Q2	$27K	Buy	+12,000	New	+$27K	0.02%	144

Compton Capital Management's RXII Position: Q4 2016 in Review

Compton Capital Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 15,000 shares — an estimated $5K sold.

Compton Capital Management first reported a position in RXII in Q2 2013 and held it in 13 quarters. The position peaked at $60K in Q4 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Compton Capital Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Compton Capital Management sold 15,000 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $5K.
Compton Capital Management first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 13 quarters.
Compton Capital Management's GALENA BIOPHARMA INC COM position peaked at $60K in Q4 2013.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Compton Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.